期刊文献+

ACS患者动脉粥样斑块稳定性相关细胞因子变化的临床意义 被引量:1

Changes of Cytokines Associated with Atherosclerotic Plaque Stability in Patients with Acute Coronary Syndrome
暂未订购
导出
摘要 目的:探讨急性冠脉综合征(ACS)病人血清中的细胞因子基质金属蛋白酶-1(MMP-1)、金属蛋白酶组织抑制剂-1(TIMP1)、sICAM-1、sVCAM-1水平与冠状动脉粥样硬化斑块稳定性的相关性及临床意义。方法:用ELISA检测ACS病人血清中sICAM-1、sVCAM-1、MMP-1、TIMP-1水平,并与正常对照组进行比较分析。结果:ACS组血清sICAM-1、sVCAM-1、MMP-1、TIMP-1水平均非常明显地高于正常对照组(P<0.01)。结论:外周血中sICAM-1、sVCAM-1、MMP-1、TIMP-1水平增高与ACS相关,能反映冠脉粥样硬化斑块的稳定情况,可作为评价冠状动脉粥样硬化斑块稳定性与病变严重程度的一个参考指标。 Objective To investigate the correlation between serum level of relevent cytokines(Matrix metalloproteinase-1,MMP-1,Tissue inhibitor of metalloproteinase-1,TIMP1-1,Intercellular adhesion molecule-1,ICAM-1,vascular intercellular adhesion molecule-1,VCAM-1 and atherosclerotic plaque stability.Methods The serum levels of ICAM-1,VCAM-1,MMP-1 and TIMP-1 were measured with ELISA in 32 patients with ACS and 30 controls.Results Serum ICAM-1,VCAM-1,MMP-1 and TIMP-1 concentrations were significantly higher in ACS patients than those in controls(P〈0.01).Conclusion The serum levels of ICAM-1,VCAM-1,MMP-1 and TIMP-1 might reflect the stability of atherosclerotic plaque in patients with acute coronary syndrome.
出处 《放射免疫学杂志》 CAS 2009年第6期618-619,共2页 Journal of Radioimmanology
  • 相关文献

参考文献6

二级参考文献31

  • 1陆金春,冯大新,尹兴昌.肺炎衣原体感染与动脉粥样硬化相关性的研究进展(英文)[J].中国现代医学杂志,2004,14(18):48-54. 被引量:7
  • 2Hwang SJ, Ballantyne CM, Richey Sharrett A, et al. Circulating adhesion molecules VCAM - 1, ICAM - 1, and E-selection in carotid atherosclerosis and incident coronary heart disease cases:The atherosclerosis risk in communities(ARIC) study [J]. Circulation
  • 3Mach F, Schonbeck U,Sukhova GK, et al. Functional CD40 ligand is expressed on human vascular endothelial cells, snooth muscle cells, and macrophages: Implication for CD40- CD40L ligand signaling in atherosclerosis [J].Proc Natl Acad Sci USA,1997,94:1 931
  • 4Hillis GS,Terregino C,Taggart P, et al. Elevated soluble P-selectin levels are associated with an increased risk of early adverse events in patients with presumed myocardial ischemia [J]. Am Heart J,2002,143(2) :235 ~ 241.
  • 5MulVihill NT, Foley JB.Inflammation in acute coronary syndromes [J].Heart,2002,87(3) :201 - 204.
  • 6Yellin MJ, Brett J, Baum D, et al. Functional interactions of T cells with endothelial cells: the role of CD40L-CD40-mediated signals [J]. J Exp Med, 1995,182(6): 1 857 - 1 864.
  • 7Herlnann A, Schror K, Weber AA, et al. CD40 ligand(CD40L) does not stimulate proliferation of vascular smooth muscle cells [J]. Eur J Cell Biol,2002,81(4) :213 - 221.
  • 8Garlichs CD, Eskafi S, Raaz D, et al. Patients with acute coronary syndromes express enhanced CD40 ligand/CD 154 on platelets [J]. Heart,2001,86(6):605-606.
  • 9Schonbeck U, Sukhova GK, ShimiZU K, et al. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice [J]. Proc Natl Acad Sci USA,2000,97(13):7 458 -7 463.
  • 10Libby P. Current concept of the pathogenesis of the acute coronary syndromes[J]. Circulation,2001,104:365.

共引文献21

同被引文献10

  • 1李旭平,张志辉,周胜华,刘启明,胡信群,祁述善.冠状动脉斑块形态与CD40配体及妊娠相关蛋白酶-A的关系[J].中国介入心脏病学杂志,2005,13(1):28-30. 被引量:11
  • 2辛辉.经皮腔内冠状动脉成形术后CK-MB及TNT的变化[J].青岛大学医学院学报,2005,41(2):123-124. 被引量:4
  • 3Otake H, Shite J, Shinke T, et al. Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome [J]. Am J Cardiol, 2008,101(1) :1 -7.
  • 4Nallamothu BK, Bates ER. Periprocedural myocardial infarction and mortality:causality versus association[ J]. J Am Coll Cardiol,2003, 42(8) :1412 - 1414.
  • 5loannidis JP, Karvouni E, Katritsis DG. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention [ J]. J Am Coll Cardiol, 2003,42 ( 8 ) : 1406 - 1411.
  • 6Laufs U, Kilter H, Konkol C, et al. Impact of HMG CoA reductase inhibition on small GTPascs in the heart( J]. Cardiovasc Res,2002, 53(4) :911 -920.
  • 7Calabrb P,Yeh ET. The pleiotropic effects of statins[ J]. Curr Opin Cardiol,2005,20 ( 6 ) : 541 - 546.
  • 8Albert MA, Danielson E, Rifai N, et al. Effect of statin therapy on C- reactive protein levels:the pravastatin inflammation/CRP evaluation (PRINCE) :a randomized trial and cohort study[J]. JAMA,2001, 286( 1 ) :64 -70.
  • 9Pasceri V, Chang J, Willerson JT, et al. Modulation of C-reactive protein mediated monocyte chemoattractant pretein-1 induction in human endothelial cells by anti-atheroscleresis drugs [J].Circulation,2001,103(21 ) :2531 -2534.
  • 10余强,马根山.急性冠状动脉综合征患者血浆sCD40L和MMP-9的变化及相关性研究[J].蚌埠医学院学报,2007,32(5):519-521. 被引量:8

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部